The most common and cheapest form of vitamin B12. Keeps your nerves healthy and your red blood cells pumping. Keeps nerve insulation, red blood cell formation and DNA copying running. It also converts homocysteine back into methionine as part of normal methylation.
Reviewed March 2026
Public health figures for this ingredient, reported by the agencies that publish them, cited and dated.
USDA advises fortified foods or supplements after 50
In its national intake tables USDA notes that "it is advised that individuals over 50 meet their B12 requirement with fortified foods or supplements".
USDA ARS, Usual Nutrient Intake from Food and Beverages, by Gender and Age, WWEIA NHANES 2013-2016, Table A 26 (vitamin B12), table note. ↗About 11% of US girls aged 14 to 18
take in less vitamin B12 from food and drink than the estimated average requirement.
USDA ARS, Usual Nutrient Intake from Food and Beverages, by Gender and Age, WWEIA NHANES 2013-2016, Table A 26 (vitamin B12), females 14-18: 11% below EAR (SE 2.4). ↗About 8% of US women aged 19 and over
take in less vitamin B12 from food and drink than the estimated average requirement.
USDA ARS, Usual Nutrient Intake from Food and Beverages, by Gender and Age, WWEIA NHANES 2013-2016, Table A 26 (vitamin B12), females 19+: 8% below EAR (SE 1.2). ↗Population figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.
Source: NIH ODS + Allen 2009 B12 review
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Cyanocobalamin has emerging evidence. Based on 8244+ studies.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Methionine synthase needs methylcobalamin and 5-methyltetrahydrofolate together to remethylate homocysteine. Without B12 the folate is stuck in its methyl form and cannot re-enter the folate cycle.
Folic acid feeds the same folate cycle that methionine synthase draws on, and that enzyme cannot turn over without B12. Supplying folate without B12 leaves the shared step limited by B12.
B12 recycles homocysteine back to methionine while B6 as pyridoxal phosphate drives the transsulfuration enzymes that route it to cysteine. Together they cover both exits from that junction.
Methionine synthase reductase uses FAD to keep the cobalamin cofactor in its reduced active state, and MTHFR upstream is also FAD-dependent. Riboflavin status therefore limits how well supplied B12 can be used.
Betaine remethylates homocysteine through BHMT without needing B12, so it covers the same step by a second route in liver and kidney.
Cyanocobalamin is a stable storage form that the body must strip of its cyanide group and reduce before it becomes methyl- or adenosylcobalamin. Stacking it with another B12 form adds to one nutrient total rather than two.
Adenosylcobalamin is one of the two active coenzyme forms cyanocobalamin is converted into, serving methylmalonyl-CoA mutase in mitochondria. They fill the same requirement from different starting points.
High concentrations of ascorbate degrade cobalamin in solution by reducing and destabilising the cobalt centre. Long-standing formulation practice separates a large vitamin C dose from B12 in liquids.
Normal red blood cell production needs B12 and folate for DNA synthesis in the marrow and iron for the haemoglobin those cells carry. Supplying one without the other leaves the other limiting.
Uptake of the intrinsic factor and B12 complex by the cubilin receptor in the ileum is calcium-dependent. Without available calcium at that step the complex is not internalised.
Biotin-dependent propionyl-CoA carboxylase makes methylmalonyl-CoA, and the B12-dependent mutase converts it onward to succinyl-CoA. The two vitamins sit in series in propionate and odd-chain fatty acid metabolism.
Methylcobalamin, the form made from cyanocobalamin inside the cell, is the cofactor that lets methionine synthase move a methyl group from 5-methyltetrahydrofolate onto homocysteine to regenerate methionine. Cobalamin supply and methionine turnover therefore sit on the same short pathway. Supplementing methionine changes the substrate side of that reaction while cobalamin governs the enzyme side. No combination trial is being cited here; this is settled pathway biochemistry.
S-adenosylmethionine is made from methionine, and methionine regeneration from homocysteine depends on a cobalamin-dependent enzyme. Low cobalamin status slows that regeneration step, so the pool feeding SAM-e synthesis narrows. Taking SAM-e supplies the methyl donor directly and bypasses the cobalamin-dependent step rather than replacing it. Homocysteine is a biochemical marker here, not a clinical outcome.
Betaine-homocysteine methyltransferase, one of the two routes that hand a methyl group to homocysteine, is a zinc-dependent metalloenzyme, while the parallel methionine synthase route depends on the cobalamin cofactor. The two nutrients support different arms of the same methyl-transfer step and are complementary rather than interchangeable. This is enzymology, not a claim about any measured combined effect in people.
Cob(II)alamin bound to methionine synthase is periodically oxidised and has to be reduced again before the enzyme can turn over. That reactivation is carried out by methionine synthase reductase using NADPH, which is built on a niacin-derived nucleotide. Adequate niacin status therefore keeps the cobalamin cofactor cycling. The relationship is a cofactor dependency, not a demonstrated additive effect.
Copper is required for the ferroxidase activity that loads iron onto transferrin, and cobalamin is required for the DNA synthesis that lets erythroid precursors divide normally. Both therefore feed normal red blood cell production from different directions. Correcting one does not compensate for a shortfall in the other. Stated as pathway biochemistry rather than as a tested pairing.
When cobalamin is restored after a period of low status, red cell production accelerates and new cells take up potassium from the extracellular space. Serum potassium can fall during that burst of cell formation. Clinicians monitor it for exactly this reason. This is a recognised handling interaction, not a benefit claim for taking the two together.
Food-bound cobalamin has to be released from its protein carriers by gastric acid and pepsin before intrinsic factor can bind it. Crystalline cyanocobalamin in a supplement arrives already free, so it does not depend on that release step. Where gastric acidity is low, added acid support bears on food-bound cobalamin rather than on the crystalline supplemental form. The distinction is mechanistic, not a tested combination.
Many gut bacteria both produce and consume corrinoids, and some make cobalamin analogues that bind human transport proteins without acting as cofactors. Shifting the microbial community can therefore change the corrinoid environment of the colon. Human cobalamin absorption happens upstream in the ileum, so the practical size of this effect is unsettled. Labelled Early because the direction of the effect in people is not established.
Activated charcoal adsorbs a wide range of small molecules in the gut lumen without selecting for what is useful. Taking it in the same window as an oral micronutrient dose lowers how much of that dose stays available for absorption. Spacing the two apart is standard formulation and dosing practice. This is an interference to flag, not a benefit.
Viscous soluble fibre thickens intestinal contents and slows the diffusion of small solutes toward the mucosal surface. For a nutrient absorbed by a saturable receptor route in a defined stretch of ileum, that can shift how much is taken up per dose. The size of the effect for cobalamin specifically has not been quantified in people. Flagged as a timing consideration at low confidence.
Cyanocobalamin and methylcobalamin are both corrinoids that use intrinsic factor, the ileal cubam receptor and transcobalamin to reach tissues, so they draw on the same saturable route and do not stack independently. Inside the cell each is processed to the same two active cofactor forms, differing in which ligand has to be removed first. Combining them does not add a separate mechanism. Neither is presented here as the one to choose.
Talk to a doctor before taking Cyanocobalamin if any of these apply to you: Methylcobalamin may be preferred for certain genetic variants (MTHFR), Absorption requires intrinsic factor (older adults may need higher doses), The cyanide component is negligible but concerns some consumers. These are flags to check first, not effects Cyanocobalamin is known to cause.
Not medical advice. Show the label to your pharmacist.The body strips off the cyanide part and converts it into the two active B12 forms it uses.
One active form of B12 keeps the folate cycle turning over and helps recycle homocysteine into methionine.
Only a little B12 can go through the main absorption door at once, so large doses rely on a slow second route that lets a small fraction through.
B12 travels in the blood on carrier proteins and the liver keeps a reserve.
Bacteria grown in a tank make the B12. It is then extracted, converted into the stable cyanide-tipped version, and crystallised.
Built by fermentation, the same way vitamin B12 and many amino acids are made at scale. Controlled conditions, consistent output.
A carbohydrate feed such as beet molasses or glucose is supplemented with a cobalt salt, since the cobalt sits at the centre of the finished molecule, and with 5,6-dimethylbenzimidazole for the lower ligand.
Cobalamin has no viable total chemical synthesis at industrial scale and no plant makes it, so all commercial material comes from bacterial biosynthesis. Industrial strains are commonly Pseudomonas denitrificans or Propionibacterium species.
The cells are broken and heated in water. A cyanide salt is added, which displaces the native upper ligands and converts the mixture of cobalamins the bacteria made into the single cyano form.
Adsorption and chromatography separate cyanocobalamin from fermentation broth components and from cobalamin analogues, which is the step that determines corrinoid purity.
The purified material is crystallised as dark red needles, assayed, then either used directly or blended down into a percentage trituration on a carrier.
Labels rarely state which production organism was used, whether the fermentation medium contained animal-derived nutrients, or the corrinoid analogue purity of the lot.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
These are the studies our verdict leans on, chosen from the 8 we read for Cyanocobalamin. The full linked list is below.
Read this carefully. These are 944,470 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Cyanocobalamin is, not how risky it is. A report is not proof Cyanocobalamin caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
